Search the Site

Twitter

test tubes

 

Some of the features of BioRunUp.com include:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regulatory Catalyst Database with over 400 events and updated daily
- Members Only Live Interactive Webinars
- Live Chat Room
- Video Lessons / Trade Reviews
- Run-Up Valuation Studies
- Weekly Video Watchlist
- SMS Alerts of breaking biotech news
- Access to Mark Messier and Mike Havrilla's Trading Accounts 
- Watch FOUR Profitable Biotech Traders in Real Time
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

The cost for an annual subscription is $697 and includes all the above features. We also offer a monthly plan for $99.95

CLICK HERE TO JOIN BIORUNUP

Take a look at excerpts from BioRunUp subscriber testimonials:

"My most recent and profitable trade are the EXAS Oct $5 options which I purchased at $.40 off of BioRunUp blog alert. They are currently yielding a 700% return!!!"

"Within 1 month my brand new porfolio was up over 23%!"

"In the first month I made a 13% return, doubling the return of the market as a whole - without leverage. To date, I have never failed to beat the market when applying the methods outlined in the pages of BioRunUp."

"I don’t ever take recommendations from people on the Internet, but this one looked right, felt right and sounded right. Thanks BioRunUp, you made me a fortune."


To read more testimonials, click HERE

 

 

 

 

 

 

 

 

 

 

Recent verified trading profits of over $1,000,000

Mark Messier

Mike Havrilla

 

Recent articles

 

$EGRX Eagle Pharma: Improving Drugs Through The 505(b)(2) NDA Route

(in: Articles)
 

BioRunUp Webinar - Thursday 7/24/14 4:30pm ET

(in: Articles)
 

Catalyst Summary For 7-22-14

(in: Articles)
 

$EXAS Exact Sciences Prepares For Cologuard Launch

(in: Articles)
 

$TKMR Tekmira Poised To Rebound From Clinical Hold Setback

(in: Articles)
 

$RMTI Rockwell Medical Seeks To Expand Dialysis Product Mix

(in: Articles)
 

This Week's Watchlist 07/21/14

(in: Articles)
 

Ralph's Notes On Recent Biotech IPOs

(in: Articles)
 

$NKTR Nektar Poised For Run-Up Into 9/16 PDUFA Catalyst

(in: Articles)
 

$POZN Pozen Seeks FDA Approval For A Safer Version Of Aspirin

(in: Articles)
 

$HRTX Heron Therapeutics: Phase 3 & FDA Catalysts Pending For Sustol

(in: Articles)
 

$ATOS Atossa Seeks FDA Approval To Re-Launch Breast Cancer Test

(in: Articles)
 

$ACST $NEPT Acasti Awaits September Krill Oil Clinical Data Catalysts

(in: Articles)
 

This Week's Watchlist 7/14/14

(in: Articles)
 

07/10/14 Webinar Available for On Demand Viewing

(in: Articles)
 

$CERS Cerus: Blood Device Specialist With 2H14 Catalysts

(in: Articles)
 

BioRunUp Webinar - Thursday 7/10/14 4:30pm ET

(in: Articles)
 

Writing Put Options and $POZN Trade Overview

(in: Articles)
 

This Week's Watchlist 07/07/14

(in: Articles)
 

$PSDV $ALIM pSivida & Alimera Make Fourth Attempt At ILUVIEN FDA Approval

(in: Articles)